Tower Research Capital (TRC)’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-500
Closed -$1K 4681
2019
Q1
$1K Buy
+500
New +$1K ﹤0.01% 3703
2018
Q3
Sell
-1,661
Closed -$6K 4519
2018
Q2
$6K Buy
1,661
+427
+35% +$1.54K ﹤0.01% 3035
2018
Q1
$4K Sell
1,234
-7,756
-86% -$25.1K ﹤0.01% 2826
2017
Q4
$28K Buy
8,990
+5,734
+176% +$17.9K ﹤0.01% 1816
2017
Q3
$23K Buy
3,256
+2,956
+985% +$20.9K ﹤0.01% 2664
2017
Q2
$3K Sell
300
-600
-67% -$6K ﹤0.01% 2284
2017
Q1
$10K Buy
900
+472
+110% +$5.24K ﹤0.01% 1808
2016
Q4
$3K Buy
+428
New +$3K ﹤0.01% 3337